REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
20/06/2026
Voltar para busca
Dado oficial do USPTO
MMDX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
66
Atualização mais recente
21/06/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
44
Data de depósito
15/01/2014
Data de registro
20/06/2017
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
08/12/2023
Última transação
21/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
702
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
3
Tipo de titular
03
Localização do titular
Edmonton, Alberta, CA
Examinador
NEVILLE, BRIAN
Unidade examinadora
M50
Localização atual
TMO LAW OFFICE 114
Descrição da marca
The mark consists of An arrow surrounding the letters "MMDx".
Titulares e representantes
Titulares
Transcriptome Sciences Inc.
Representantes
Connie Ellerbach Fenwick & West LLP
Classificação técnica
Classes Nice
Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 44
Providing integrated diagnostic system services comprised of quantitative RNA services comprised of quantitative RNA measurement technologies including microarrays and RT-PCR to assess the disease states in tissue biopsies; Diagnostic testing using molecular diagnostic technology; Provision of diagnostic system services comprised of quantitative RNA measurement technologies including microarrays and RT-PCR to assess tissue biopsies by measuring RNA, mRNA and micro RNA expressions; Providing moleculor diagnostic testing services; Providing molecular diagnostic testing services on tissue biopsies; Providing diagnostic testing and assessment services relating to the assessment of tissue biopsies for disease diagnosis, activity, stage, potential for therapy (theranostics), response to therapy, prognosis and treatment; Converting RNA measurements into diagnostic information to assess the biopsy for diagnosis, activity, stage, potential for therapy (theranostics), response to therapy, and prognosis of the patient; Providing data analysis services in the field of diagnostic testing, assessment, management, analysis, and reporting; Providing medical diagnostic services featuring a virtual integrated diagnostic system that uses molecular technology to assess the disease state in tissue biopsies
Publicações
Histórico de despachos e eventos da marca no USPTO.
66 publicações encontradas
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08/12/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/12/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/12/2023
E815
TEAS SECTION 8 & 15 RECEIVED
09/06/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
29/06/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
29/06/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
29/06/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
20/06/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
15/08/2019
CORV
REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED
15/08/2019
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
14/08/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/12/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/12/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
20/06/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/04/2017
PUBO
PUBLISHED FOR OPPOSITION
04/04/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
15/03/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
28/02/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/02/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
31/01/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
27/01/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
27/01/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
27/01/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
18/01/2017
GNRT
NON-FINAL ACTION E-MAILED
18/01/2017
CNRT
NON-FINAL ACTION WRITTEN
18/01/2017
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
19/12/2016
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
06/12/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
18/11/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/11/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
31/10/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
31/10/2016
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
25/10/2016
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
21/06/2016
GNSL
LETTER OF SUSPENSION E-MAILED
21/06/2016
CNSL
SUSPENSION LETTER WRITTEN
21/06/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/06/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/06/2016
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
27/05/2016
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/12/2015
GNSL
LETTER OF SUSPENSION E-MAILED
01/12/2015
CNSL
SUSPENSION LETTER WRITTEN
01/12/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/11/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/11/2015
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
18/11/2015
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/06/2015
GNSL
LETTER OF SUSPENSION E-MAILED
03/06/2015
CNSL
SUSPENSION LETTER WRITTEN
03/06/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/05/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/05/2015
ALIE
ASSIGNED TO LIE
11/05/2015
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
07/05/2015
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
13/11/2014
GNSL
LETTER OF SUSPENSION E-MAILED
13/11/2014
CNSL
SUSPENSION LETTER WRITTEN
13/11/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/10/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/10/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
23/10/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
24/04/2014
GNRT
NON-FINAL ACTION E-MAILED
24/04/2014
CNRT
NON-FINAL ACTION WRITTEN
24/04/2014
DOCK
ASSIGNED TO EXAMINER
17/04/2014
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
29/01/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
28/01/2014
NWAP
NEW APPLICATION ENTERED
18/01/2014
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MMDX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.